Skip to search formSkip to main contentSkip to account menu

morpholinoanthracycline MX2

Known as: 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin, MX-2, morpholinoanthracycline MX-2 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Antibiotics, AntineoplasticCarubicin

Narrower (1)

KRN 8602
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Induction of Mx-2 in rat liver by toxic injury.
1993
1993
MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in refractory metastatic breast cancer: results of a preliminary phase II trial.
We performed a preliminary phase II clinical trial of MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in… 
1988
1988
[Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
MX-2, a new morpholino anthracycline derivative, showed broad anti-neoplastic activity against experimental tumors. Molecular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)